Name: Latest research reports of Divi's Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6593.0000 27.50 (0.42%)

NSE Oct 24, 2025 15:31 PM

33.06% Gain from 52W Low

Volume: 250.6K

Divi's Laboratories Ltd.

12 Aug 2019

6593.00

0.42%

Adverse macro situation for raw materials impacts profitability

Neutral: Divi's Laboratories Ltd.

Motilal Oswal

Adverse macro situation for raw materials impacts profitability Motilal Oswal values your support in the Asiamoney Brokers Poll 2019 for...

Divi's Laboratories .. has an average target of 6414.33 from 6 brokers.